International Medicine and Health Guidance News ›› 2025, Vol. 31 ›› Issue (4): 562-567.DOI: 10.3760/cma.j.cn441417-20240902-04008
• New Medical Advances • Previous Articles Next Articles
Research progress of mesenchymal stem cells in neurodegenerative diseases
Wang Xingxing, Zhang Xiaolin, Wang Yanfei
Department of Otorhinolaryngology, Head, and Neck Surgery, Binzhou Medical University Hospital, Binzhou 256603, China
Received:
2024-09-02
Online:
2025-02-15
Published:
2025-02-24
Contact:
Wang Yanfei, Email: entwyf@163.com
Supported by:
Natural Science Foundation in Shandong Province (ZR2023MH372); "Clinical +X" Project of Binzhou Medical University (BY2021LCX25)
间充质干细胞在神经退行性疾病中的研究进展
王兴兴 张肖林 王延飞
滨州医学院附属医院耳鼻咽喉头颈外科,滨州 256603
通讯作者:
王延飞,Email:entwyf@163.com
基金资助:
山东省自然科学基金(ZR2023MH372);滨州医学院“临床+X”项目(BY2021LCX25)
Wang Xingxing, Zhang Xiaolin, Wang Yanfei.
Research progress of mesenchymal stem cells in neurodegenerative diseases [J]. International Medicine and Health Guidance News, 2025, 31(4): 562-567.
王兴兴 张肖林 王延飞.
间充质干细胞在神经退行性疾病中的研究进展 [J]. 国际医药卫生导报, 2025, 31(4): 562-567.
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.imhgn.com/EN/10.3760/cma.j.cn441417-20240902-04008
[1] Rahimi A, Sameei P, Mousavi S, et al. Application of CRISPR/cas9 system in the treatment of alzheimer's disease and neurodegenerative diseases[J].Mol Neurobiol,2024,61(11):9416-9431.DOI:10.1007/s12035-024- 04143-2. [2] Reyhani S, Abbaspanah B, Mousavi SH. Umbilical cord-derived mesenchymal stem cells in neurodegenerative disorders: from literature to clinical practice[J].Regen Med,2020,15(4):1561-1578.DOI:10.2217/rme-2019-0119. [3] Shariati A, Nemati R, Sadeghipour Y, et al. Mesenchymal stromal cells (MSCs) for neurodegenerative disease: a promising frontier[J].Eur J Cell Biol,2020,99(6):151097.DOI:10.1016/j.ejcb.2020.151097. [4] Palanisamy CP, Pei J, Alugoju P, et al. New strategies of neurodegenerative disease treatment with extracellular vesicles (EVs) derived from mesenchymal stem cells (MSCs)[J].Theranostics,2023,13(12):4138-4165.DOI:10.7150/thno.83066. [5] Sadatpoor SO, Salehi Z, Rahban D, et al. Manipulated mesenchymal stem cells applications in neurodegenerative diseases[J].Int J Stem Cells,2020,13(1):24-45.DOI:10.15283/ijsc19031. [6] Paliwal S, Chaudhuri R, Agrawal A, et al. Human tissue-specific MSCs demonstrate differential mitochondria transfer abilities that may determine their regenerative abilities[J].Stem Cell Res Ther,2018,9(1):298.DOI:10.1186/s13287-018-1012-0. [7] Chen Y, Shen H, Ding Y, et al. The application of umbilical cord-derived MSCs in cardiovascular diseases[J].J Cell Mol Med,2021,25(17):8103-8114.DOI:10.1111/jcmm.16830. [8] Yang Y, Ye G, Zhang YL, et al. Transfer of mitochondria from mesenchymal stem cells derived from induced pluripotent stem cells attenuates hypoxia-ischemia-induced mitochondrial dysfunction in PC12 cells[J].Neural Regen Res,2020,15(3):464-472.DOI:10.4103/1673-5374.266058. [9] Chen W, Zhuo Y, Duan D, et al. Effects of hypoxia on differentiation of mesenchymal stem cells[J].Curr Stem Cell Res Ther,2020,15(4):332-339.DOI:10.2174/1574888X14666190823144928. [10] Heneghan A, Deng F, Wells K, et al. Modifiable lifestyle activities affect cognition in cognitively healthy middle-aged individuals at risk for late-life alzheimer's disease[J].J Alzheimers Dis,2023,91(2):833-846.DOI:10.3233/JAD-220267. [11] 陶晶,杨晓帆,赵志轩,等.针刺疗法对AD大鼠的治疗作用及其机制的实验研究[J].国际医药卫生导报,2023,29(3):342-347.DOI:10.3760/cma.j.issn.1007-1245.2023.03.010. [12] Si ZZ, Zou CJ, Mei X, et al. Targeting neuroinflammation in alzheimer's disease: from mechanisms to clinical applications[J].Neural Regen Res,2023,18(4):708-715.DOI:10.4103/1673-5374.353484. [13] Katolikova NV, Malashicheva AB, Gainetdinov RR. Cell replacement therapy in parkinson's disease-history of development and prospects for Use in clinical practice[J].Mol Biol (Mosk),2020,54(6):939-954.DOI:10.31857/S0026898420060063. [14] Tarakad A, Jankovic J. Recent advances in understanding and treatment of parkinson's disease[J].Fac Rev,2020,9:6.DOI:10.12703/b/9-6. [15] Kim G, Gautier O, Tassoni-Tsuchida E, et al. ALS genetics: gains, losses, and implications for future therapies[J].Neuron,2020,108(5):822-842.DOI:10.1016/j.neuron.2020.08.022. [16] Mead RJ, Shan N, Reiser HJ, et al. Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation[J].Nat Rev Drug Discov,2023,22(3):185-212.DOI:10.1038/s41573-022-00612-2. [17] Li L, Liu J, She H. Targeting macrophage for the treatment of amyotrophic lateral sclerosis[J].CNS Neurol Disord Drug Targets,2019,18(5):366-371.DOI:10.2174/1871527318666190409103831. [18] 黄治物,吴皓.年龄相关性听力损失研究进展与临床干预策略[J].上海交通大学学报(医学版),2022,42(9):1182-1187.DOI:10.3969/j.issn.1674-8115.2022.09.004. [19] Loughrey DG, Kelly ME, Kelley GA, et al. Association of age-related hearing loss with cognitive function, cognitive impairment, and dementia: a systematic review and meta-analysis[J].JAMA Otolaryngol Head Neck Surg,2018,144(2):115-126.DOI:10.1001/jamaoto.2017.2513. [20] Razavi S, Razavi MR, Zarkesh Esfahani H, et al. Comparing brain-derived neurotrophic factor and ciliary neurotrophic factor secretion of induced neurotrophic factor secreting cells from human adipose and bone marrow-derived stem cells[J].Dev Growth Differ,2013,55(6):648-655.DOI:10.1111/dgd.12072. [21] Ren J, Liu Y, Yao Y, et al. Intranasal delivery of MSC-derived exosomes attenuates allergic asthma via expanding IL-10 producing lung interstitial macrophages in mice[J].Int Immunopharmacol,2021,91:107288.DOI:10.1016/j.intimp.2020.107288. [22] Boukelmoune N, Laumet G, Tang Y, et al. Nasal administration of mesenchymal stem cells reverses chemotherapy-induced peripheral neuropathy in mice[J].Brain Behav Immun,2021,93:43-54.DOI:10.1016/j.bbi.2020.12.011. [23] Ge Y, Wu J, Zhang L, et al. A new strategy for the regulation of neuroinflammation: exosomes derived from mesenchymal stem cells[J].Cell Mol Neurobiol,2024,44(1):24.DOI:10.1007/s10571-024-01460-x. [24] Kubota K, Nakano M, Kobayashi E, et al. An enriched environment prevents diabetes-induced cognitive impairment in rats by enhancing exosomal miR-146a secretion from endogenous bone marrow-derived mesenchymal stem cells[J].PLoS One,2018,13(9):e0204252.DOI:10.1371/journal.pone.0204252. [25] Zhu J, Yang J, Xu J. miR-223 inhibits the polarization and recruitment of macrophages via NLRP3/IL-1β pathway to meliorate neuropathic pain[J].Pain Res Manag,2021,2021:6674028.DOI:10.1155/2021/6674028. [26] Oveili E, Vafaei S, Bazavar H, et al. The potential use of mesenchymal stem cells-derived exosomes as microRNAs delivery systems in different diseases[J].Cell Commun Signal,2023,21(1):20.DOI:10.1186/s12964-022-01017-9. [27] Han D, Zheng X, Wang X, et al. Mesenchymal stem/stromal cell-mediated mitochondrial transfer and the therapeutic potential in treatment of neurological diseases[J].Stem Cells Int,2020,2020:8838046.DOI:10.1155/2020/8838046. [28] Lane CA, Hardy J, Schott JM. Alzheimer's disease[J].Eur J Neurol,2018,25(1):59-70.DOI:10.1111/ene.13439. [29] 李文玉,金日龙,胡兴越.PKH26标记的骨髓间质干细胞在阿尔茨海默病大鼠中的迁移[J].浙江大学学报(医学版),2012,41(6):659-664.DOI:10.3785/j.issn.1008-9292. 2012.06.009. [30] Kim HJ, Cho KR, Jang H, et al. Intracerebroventricular injection of human umbilical cord blood mesenchymal stem cells in patients with alzheimer's disease dementia: a phase I clinical trial[J].Alzheimers Res Ther,2021,13(1):154.DOI:10.1186/s13195-021-00897-2. [31] Shi JX, Zhang KZ. Advancements in autologous stem cell transplantation for parkinson's disease[J].Curr Stem Cell Res Ther,2024,19(10):1321-1327.DOI:10.2174/1574888X19666230907112413. [32] Rodríguez-Pallares J, García-Garrote M, Parga JA, et al. Combined cell-based therapy strategies for the treatment of parkinson's disease: focus on mesenchymal stromal cells[J].Neural Regen Res,2023,18(3):478-484.DOI:10.4103/1673-5374.350193. [33] Abrishamdar M, Jalali MS, Yazdanfar N. The role of exosomes in pathogenesis and the therapeutic efficacy of mesenchymal stem cell-derived exosomes against parkinson's disease[J].Neurol Sci,2023,44(7):2277-2289.DOI:10.1007/s10072-023-06706-y. [34] Unnisa A, Dua K, Kamal MA. Mechanism of mesenchymal stem cells as a multitarget disease- modifying therapy for parkinson's disease[J].Curr Neuropharmacol,2023,21(4):988-1000.DOI:10.2174/1570159X20666220327212414. [35] Abrishamdar M, Jalali MS, Yazdanfar N. The role of exosomes in pathogenesis and the therapeutic efficacy of mesenchymal stem cell-derived exosomes against parkinson's disease[J].Neurol Sci,2023,44(7):2277-2289.DOI:10.1007/s10072-023-06706-y. [36] Van den Bos J, Ouaamari YE, Wouters K, et al. Are cell-based therapies safe and effective in the treatment of neurodegenerative diseases? A systematic review with meta-analysis[J].Biomolecules,2022,12(2):340.DOI:10.3390/biom12020340. [37] Wang J, Hu W, Feng Z, et al. BDNF-overexpressing human umbilical cord mesenchymal stem cell-derived motor neurons improve motor function and prolong survival in amyotrophic lateral sclerosis mice[J].Neurol Res,2021,43(3):199-209.DOI:10.1080/01616412.2020.1834775. [38] Alkhazaali-Ali Z, Sahab-Negah S, Boroumand AR, et al. Evaluation of the safety and efficacy of repeated mesenchymal stem cell transplantations in ALS patients by investigating patients' specific immunological and biochemical biomarkers[J].Diseases,2024,12(5):99.DOI:10.3390/diseases12050099. [39] Petrou P, Kassis I, Yaghmour NE, et al. A phase II clinical trial with repeated intrathecal injections of autologous mesenchymal stem cells in patients with amyotrophic lateral sclerosis[J].Front Biosci (Landmark Ed),2021,26(10):693-706.DOI:10.52586/4980. [40] Yamasoba T, Lin FR, Someya S, et al. Current concepts in age-related hearing loss: epidemiology and mechanistic pathways[J].Hear Res,2013,303:30-38.DOI:10.1016/j.heares.2013.01.021. [41] Someya S, Prolla TA. Mitochondrial oxidative damage and apoptosis in age-related hearing loss[J].Mech Ageing Dev,2010,131(7-8):480-486.DOI:10.1016/j.mad.2010.04.006. [42] 贺祖宏,李明,邹圣宇,等.老年性聋的发病机制及干预研究进展[J].中华耳鼻咽喉头颈外科杂志,2020,55(11):1105-1110.DOI:10.3760/cma.j.cn115330-20191218- 00763. [43] Pleen J, Townley R. Alzheimer's disease clinical trial update 2019-2021[J].J Neurol,2022,269(2):1038-1051.DOI:10.1007/s00415-021-10790-5. [44] Kobylecki C, Burn DJ, Kass-Iliyya L, et al. Randomized clinical trial of topiramate for levodopa-induced dyskinesia in parkinson's disease[J].Parkinsonism Relat Disord,2014,20(4):452-455.DOI:10.1016/j.parkreldis. 2014.01.016. [45] Wong C, Stavrou M, Elliott E, et al. Clinical trials in amyotrophic lateral sclerosis: a systematic review and perspective[J].Brain Commun,2021,3(4):fcab242.DOI:10.1093/braincomms/fcab242. |
[1] | Chen Yuan, Gao Mengxin, Wang Jing, Chen Yunqing, Cai Chao, Sun Hongling. Meta-analysis of the application effect of web-based decision aids in treatment decisions for prostate cancer patients [J]. International Medicine and Health Guidance News, 2025, 31(5): 706-712. |
[2] |
Li Xiaotong, Yu Shengqiang.
Research progress of tubule-derived exosomes in renal fibrosis [J]. International Medicine and Health Guidance News, 2025, 31(5): 712-718. |
[3] |
Zhang Han, Sun Ting, Wang Yanfei, Zhang Xiaolin, Che Juan.
Research progress of post-transplantation lymphoproliferative disease in children with adenotonsillar hypertrophy [J]. International Medicine and Health Guidance News, 2025, 31(5): 752-757. |
[4] |
Mo Jiachan, Fan Wanfeng, Jiang Xingyue.
Application status and progress of MRI based radiomics in pituitary adenoma [J]. International Medicine and Health Guidance News, 2025, 31(5): 757-760. |
[5] |
Li Nan, Sun Shuangchun, Yan Yuqiang, Zhang Qin.
Effect of continuous thoracic paravertebral block with ropivacaine on patients undergoing video-assisted thoracoscopic lobectomy [J]. International Medicine and Health Guidance News, 2025, 31(5): 801-805. |
[6] |
Zhang Yiyi, Zheng Zhou, Liu Qian.
Effect of adalimumab combined with Guanzhong Li's bone injury school decompression and pain relief method on hip joint function in patients with ankylosing spondylitis [J]. International Medicine and Health Guidance News, 2025, 31(5): 818-822. |
[7] |
He Jiani, Liu Yanguan, Feng Weixing, Hao Tao.
Clinical efficacy and safety of Tongdu Yisui acupuncture combined with Ningshen Zhichou decoction in the treatment of pediatric Tourette syndrome with internal stirring of liver wind [J]. International Medicine and Health Guidance News, 2025, 31(5): 823-827. |
[8] |
Han Zhao, Zhang Wei, Zhang Xulong.
Effect of Xingnao Kaiqiao acupuncture combined with Jiawei Ditan decoction on post-stroke aphasia patients with wind phlegm obstruction syndrome [J]. International Medicine and Health Guidance News, 2025, 31(5): 833-838. |
[9] |
Cao Dongdong, Nie Juanli.
Effect of standardized chemotherapy regimen combined with Baihe Dihuang decoction on elderly patients with pulmonary tuberculosis [J]. International Medicine and Health Guidance News, 2025, 31(5): 839-843. |
[10] |
Liu Weifeng, Guo Yuan, Tang Wenjie, Yang Ruimeng, Fan Hao, Wei Xinhua.
"Medical + X" talent training mode for development of comprehensive capability of medical imaging graduate students [J]. International Medicine and Health Guidance News, 2025, 31(4): 530-534. |
[11] |
Hao Huihui, Feng Anhua, Ma Xiaolin, Li Ao, Ding Chuanhu.
Application of case and problem teaching model in clinical pharmacy practice teaching under SOAP thinking mode [J]. International Medicine and Health Guidance News, 2025, 31(4): 539-542. |
[12] |
Hong Jinquan, Huang Xiaoling, Huang Zhenyu, Huang Haobo.
Research progress of abnormal lipid metabolism and its intervention in diffuse large B-cell lymphoma [J]. International Medicine and Health Guidance News, 2025, 31(4): 559-562. |
[13] |
Tian Lu, Pei Ruixia, Bai Xiaolin, Zhang Ting, Zhao Meiyun.
Effect of methimazole combined with Yangyin Pingjia Decoction for patients with hyperthyroidism characterized by yin deficiency and exuberant fire [J]. International Medicine and Health Guidance News, 2025, 31(4): 578-581. |
[14] |
Gao Haohao, Li Pengju, Song Hujie.
Clinical effect of edaravone combined with Xingnaojing injection on neurological function in patients with subarachnoid hemorrhage [J]. International Medicine and Health Guidance News, 2025, 31(4): 608-612. |
[15] |
Zhong Yimin, Li Wenfang, Huang Huanrong, Zheng jieru, Xian Haiyan.
Observation on effect of low frequency electrical stimulation on back combined with Ruyi Jinhuang Powder for patients with acute mastitis during lactation period [J]. International Medicine and Health Guidance News, 2025, 31(4): 618-622. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||